The co-evolved Helicobacter pylori and gastric cancer: Trinity of bacterial virulence, host susceptibility and lifestyle

被引：21
作者：
Akhter Y. [1 ]
Ahmed I. [2 ]
Devi S.M. [1 ]
Ahmed N. [1 ]
机构：
[1] Pathogen Evolution Group, Laboratory of Molecular and Cellular Biology, Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad
[2] Department of Microbiology, Shri Shivaji College of Arts, Commerce and Science, Akola
来源：
Infectious Agents and Cancer | / 2卷 / 1期
关键词：
Gastric Cancer; Pylorus Infection; Pylorus Strain; Gastric Lymphoma; Pylorus Colonization;
D O I：
10.1186/1750-9378-2-2
中图分类号：
学科分类号：
摘要：
Helicobacter pylori is an important yet unproven etiological agent of gastric cancer. H. pylori infection is more prevalent in developing Asian countries like India and it is usually acquired at an early age. It has been two decades since Marshall and Warren (1984) first described curved bacilli in the stomach of ulcer and gastritis patients. This discovery has won them the Nobel Prize recently, but the debate whether H. pylori is a pathogen or a commensal organism is still hot. Associations with disease-specific factors remain illusive years after the genome sequences were made available. Cytotoxin-associated antigen A (CagA) and the so-called plasticity region cluster genes are implicated in pathogenesis of the carcinoma of stomach. Another virulence factor VacA whose role is still debatable, has recently been projected in pathology of gastric cancer. Studies of the evolution through genetic variation in H. pylori populations have provided a window into the history of human population migrations and a possible co-evolution of this pathogen with its human host. Possible symbiotic relationships were seriously debated since the discovery of this pathogen. The debate has been further intensified as some studies proposed H. pylori infection to be beneficial in some humans. In this commentary, we attempt to briefly discuss about H. pylori as a human pathogen, and some of the important issues linked to its pathophysiology in different hosts. 'We dance around in a ring and suppose, the secret sits in the middle and knows' - Robert Frost.
引用
收藏
相关论文
共 31 条
  • [1] Dunn B.E., Cohen H., Blaser M.J., Helicobacter pylori, Clin Microbiol Rev, 10, pp. 720-741, (1997)
  • [2] Atherton J.C., The pathogenesis of Helicobacter pylori -induced gastro-duodenal diseases, Annual Reviews in Pathology, 1, pp. 63-96, (2006)
  • [3] Devi S.M., Ahmed I., Khan A.A., Rahman S.A., Alvi A., Sechi L.A., Ahmed N., Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island, BMC Genomics, 7, (2006)
  • [4] Franchini M., Veneri D., Helicobacter pylori infection and immune thrombocytopenic purpura: An update, Helicobacter, 9, pp. 342-346, (2004)
  • [5] Jackson S., Beck P.L., Pineo G.F., Poon M.C., Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature, Am J Hematol, 78, pp. 142-150, (2005)
  • [6] Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J., Helicobacter pylori infection and the development of gastric cancer, N Engl J Med, 345, pp. 784-789, (2001)
  • [7] Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., Stemmermann G.N., Nomura A., Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach, Cancer Res, 55, pp. 2111-2115, (1995)
  • [8] Parsonnet J., Friedman G.D., Orentreich N., Vogelman H., Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection, Gut, 40, pp. 297-301, (1997)
  • [9] Hatakeyama M., Oncogenic mechanisms of Helicobacter pylori cagA protein, Nature Rev Cancer, 4, pp. 688-694, (2004)
  • [10] Yamaoka Y., Kodama T., Kashima K., Graham D.Y., Sepulveda A.R., Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pyolri-associated diseases, J Clin Microbiol, 36, pp. 2258-2263, (1998)
1234